Follow
Myeloma
Myeloma is cancer of the plasma cells. Plasma cells are white blood cells that produce disease- and infection-fighting antibodies in your body. Myeloma cells prevent the normal production of antibodies, leaving your body's immune system weakened and susceptible to infection. The multiplication of myeloma cells also interferes with the normal production and function of red and white blood cells. An abnormally high amount of these dysfunctional antibodies in the bloodstream can cause kidney damage. Additionally, the myeloma cells commonly produce substances that cause bone destruction, leading to bone pain and/or fractures.
What's Popular in Myeloma
-
JAN 17, 2023Clinical & Molecular DX
When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years ...Sponsored By: Roche Sequencing and Life ScienceDEC 30, 2022Cancer
As we near the end of 2022, and enter our fourth year of facing COVID-19 (so named because of it’s emergence in 20 ...Written By: Katie KokolusDEC 26, 2022Immunology
Almost every patient who gets myeloma and is treated with a standard therapy also experiences relapse. But researchers h ...Written By: Carmen LeitchSEP 13, 2022Cancer
Introduction Cancer is the second leading cause of death globally. According to estimates from the American Cancer Socie ...Sponsored By: Sino BiologicalJUL 11, 2022Cancer
Chimeric antigen receptor (CAR) T Cell therapy has emerged as a promising immunotherapeutic approach to treat blood canc ...Written By: Katie Kokolus
JAN 17, 2023
Clinical & Molecular DX
When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years
...
Sponsored By:
Roche Sequencing and Life Science
DEC 30, 2022
Cancer
As we near the end of 2022, and enter our fourth year of facing COVID-19 (so named because of it’s emergence in 20
...
Written By:
Katie Kokolus
DEC 26, 2022
Immunology
Almost every patient who gets myeloma and is treated with a standard therapy also experiences relapse. But researchers h
...
Written By:
Carmen Leitch
SEP 13, 2022
Cancer
Introduction Cancer is the second leading cause of death globally. According to estimates from the American Cancer Socie
...
Sponsored By:
Sino Biological
JUL 11, 2022
Cancer
Chimeric antigen receptor (CAR) T Cell therapy has emerged as a promising immunotherapeutic approach to treat blood canc
...
Written By:
Katie Kokolus
JAN 20, 2022
Immunology
Scientists studying a neglected tropical disease have made a chance discovery—a promising therapeutic targe
...
Written By:
Tara Fernandes
DEC 16, 2021
Cancer
The incidence of various cancers, including multiple myeloma, colorectal, kidney, and pancreatic cancer, is steadily&nbs
...
Written By:
Katie Kokolus
APR 11, 2021
Genetics & Genomics
Vaccines are mostly known as tools to prevent illness. But cancer vaccines are a bit different, and aim to treat existin
...
Written By:
Carmen Leitch
FEB 23, 2021
Immunology
University of Limerick researchers have discovered direct links between the immune system, specific personality traits,
...
Written By:
Tara Fernandes
-
AUG 24, 2022 8:00 AM PDT
AUG 24, 2022 8:00 AM PDTDate: August 24, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Next Generation Sequencing (NGS) has evolved rapidly since the first sequencing platforms were commercially released ne...Speaker: Dr. David Seidman, Ph.D., MB (ASCP)Sponsored By: Thermo Fisher ScientificJUN 21, 2022 11:00 AM PDT
JUN 21, 2022 11:00 AM PDTDate: June 21, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Multiple myeloma is a cancer of the plasma cell. Plasma cells are white blood cells that make antibodies that help to pro...Speaker: Dr. John MitsiosSponsored By: Siemens HealthineersNOV 30, 2021 11:00 AM PSTC.E. CREDITS
NOV 30, 2021 11:00 AM PSTDate: November 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) In the recent years, measurable residual disease (MRD) assessment on multiple myeloma patients has gained increasing relevance. After...Speaker: Juan Flores-Montero, MD, PhDSponsored By: CytognosAUG 18, 2021 8:00 AM PDTC.E. CREDITS
AUG 18, 2021 8:00 AM PDTDate: August 18, 2021 Time: 8:00am (PDT), 11:00am (EDT) Discover the tools to phenotype your NK cells and to perform functional analyses such as cellular cytotoxicity assays. From NK cell is...Speaker: Julia Hengst, PhDSponsored By: Miltenyi BiotecJUN 29, 2021 9:00 AM PDTC.E. CREDITS
JUN 29, 2021 9:00 AM PDTDate: June 29, 2021 Time: 9:00am (PDT), 12:00pm (EDT) This month’s LabRoots discussion titled “Laboratory Screening for Multiple Myeloma: A Nudge in the Direction of Guideline Co...Speaker: Jeremy Hart, MD, MBA, FCAPSponsored By: Binding Site
AUG 24, 2022
8:00 AM PDT
AUG 24, 2022
8:00 AM PDT
Date: August 24, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Next Generation Sequencing (NGS) has evolved rapidly since the first sequencing platforms were commercially released ne...
Speaker:
Dr. David Seidman, Ph.D., MB (ASCP)
Sponsored By: Thermo Fisher Scientific
JUN 21, 2022
11:00 AM PDT
JUN 21, 2022
11:00 AM PDT
Date: June 21, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Multiple myeloma is a cancer of the plasma cell. Plasma cells are white blood cells that make antibodies that help to pro...
Speaker:
Dr. John Mitsios
Sponsored By: Siemens Healthineers
NOV 30, 2021
11:00 AM PST
C.E. CREDITS
NOV 30, 2021
11:00 AM PST
Date: November 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) In the recent years, measurable residual disease (MRD) assessment on multiple myeloma patients has gained increasing relevance. After...
Speaker:
Juan Flores-Montero, MD, PhD
Sponsored By: Cytognos
AUG 18, 2021
8:00 AM PDT
C.E. CREDITS
AUG 18, 2021
8:00 AM PDT
Date: August 18, 2021 Time: 8:00am (PDT), 11:00am (EDT) Discover the tools to phenotype your NK cells and to perform functional analyses such as cellular cytotoxicity assays. From NK cell is...
Speaker:
Julia Hengst, PhD
Sponsored By: Miltenyi Biotec
JUN 29, 2021
9:00 AM PDT
C.E. CREDITS
JUN 29, 2021
9:00 AM PDT
Date: June 29, 2021 Time: 9:00am (PDT), 12:00pm (EDT) This month’s LabRoots discussion titled “Laboratory Screening for Multiple Myeloma: A Nudge in the Direction of Guideline Co...
Speaker:
Jeremy Hart, MD, MBA, FCAP
Sponsored By: Binding Site
C.E. CREDITS
Learning Objectives: 1. Learn about alternative promoters and their role in cancer 2. Learn how long read RNA-Seq helps to study the transcriptome...
Speaker:
Jonathan Göke
Presented at: Genetics Week Virtual Event Series 2021
MAR 23, 2021
9:00 AM PDT
MAR 23, 2021
9:00 AM PDT
Date: March 23, 2021 Time: 9:00am (PST), 12:00pm (EST) The chromatin regulators CBP and p300 maintain gene expression programs through lysine acetylation of chromatin and transcriptional reg...
Speaker:
Christopher Ott, PhD
,
Tim Geiger, PhD
Sponsored By: ACD - A Bio-Techne Brand
FEB 24, 2021
10:00 AM PST
C.E. CREDITS
FEB 24, 2021
10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
Speaker:
David Wasescha
,
Simon Fogarty
Sponsored By: Labconco
FEB 23, 2021
8:00 AM PST
C.E. CREDITS
FEB 23, 2021
8:00 AM PST
Date: February 23, 2021 Time: 8:00am (PST), 11:00am (EST) The analysis of serum free light chains (FLC) is now standard of care in the screening, diagnosis, and monitoring of patients suspec...
Speaker:
Dr. Kazunori Murata
Sponsored By: Binding Site
-
10/14-15 9am-1pm CDT
10/14-15 9am-1pm CDTComing to you from a safe, physical distance, 2020 Abbott World Summit. This event will feature over 15 global experts sharing their latest discoveries and experiences in cancer screening, r...10/13-14 from 1-5pm SGT
10/13-14 from 1-5pm SGTComing to you from a safe, physical distance, Abbott 2020 world oncology summit. Covering diverse and timely topics in cancer education, from updates in cancer emerging new diagnostics resea...OCT 11, 2017 6:00 AM PDT
OCT 11, 2017 6:00 AM PDTThe 5th Annual Event in the Cancer Research & Oncology Week Virtual Event Series is now On-Demand!...OCT 05, 2016 6:00 AM PDT
OCT 05, 2016 6:00 AM PDTThe 4th Annual Event in the Cancer Research & Oncology Week Virtual Event Series is now On Demand! This premier cancer research conference makes it easier...SEP 30, 2015 6:00 AM PDT
SEP 30, 2015 6:00 AM PDTWelcome to Labroots 3rd Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
10/14-15 9am-1pm CDT
10/14-15 9am-1pm CDT
Coming to you from a safe, physical distance, 2020 Abbott World Summit. This event will feature over 15 global experts sharing their latest discoveries and experiences in cancer screening, r...
10/13-14 from 1-5pm SGT
10/13-14 from 1-5pm SGT
Coming to you from a safe, physical distance, Abbott 2020 world oncology summit. Covering diverse and timely topics in cancer education, from updates in cancer emerging new diagnostics resea...
OCT 11, 2017
6:00 AM PDT
OCT 11, 2017
6:00 AM PDT
The 5th Annual Event in the Cancer Research & Oncology Week Virtual Event Series is now On-Demand!...
OCT 05, 2016
6:00 AM PDT
OCT 05, 2016
6:00 AM PDT
The 4th Annual Event in the Cancer Research & Oncology Week Virtual Event Series is now On Demand! This premier cancer research conference makes it easier...
SEP 30, 2015
6:00 AM PDT
SEP 30, 2015
6:00 AM PDT
Welcome to Labroots 3rd Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
MAY 28, 2014
6:00 AM PDT
MAY 28, 2014
6:00 AM PDT
This year will be our 5th Annual Event in the Clinical Diagnostics & Research Virtual Event Series. Attendees can earn free CME and CE Credits....
AUG 21, 2013
6:00 AM PDT
C.E. CREDITS
AUG 21, 2013
6:00 AM PDT
The theme of this conference is a range of genetics and genomics topics such as RNAi, Next-generation sequencing, Cancer research, Sequencing, Genome-wide association studies GWAS, Epigenetic...